20,000 Ghent residents will be medically monitored for 20 years: Stad Gent subsidizes massive health study.
At Ghent University Hospital the GMP unit for cell - and gene therapies we try to develop new therapies for patients that need it the most. Currently the GMP unit is expanding its capabilities beyond mRNA-LNP formulations, dentritic cell and other cell therapeutic products with on-site lentiviral vector production for early-stage academic trials. We are gratefull for the support from Stad Gent in this initiative.
Full article (in dutch): https://www.nieuwsblad.be/cnt/dmf20230314_95281702